Top Mover
UnitedHealth Raises Full-Year Guidance After Q3 Beat, Optum Health CEO Flags Multi-Year Road to 6%-8% Margins
Read this in the Market Flux appUnitedHealth Group Incorporated $UNH
$395.78+4.81%as of publication
- 5D Change
- +5.30%
- Market Cap
- $343.06B
UnitedHealth Group reported third-quarter 2026 revenues of $112.7 billion and earnings from operations of $6.6 billion, with adjusted earnings per share of $4.69. The company raised its full-year 2026 adjusted earnings outlook to at least $20.50 per share, up from prior guidance, while GAAP earnings guidance was lifted to at least $19.50 per share. The results came alongside a broader market session in which the Dow Jones Industrial Average gained 184 points, partly driven by UNH shares, even as the S&P 500 and Nasdaq fell after a hotter-than-expected September CPI print.
Optum Health posted third-quarter revenues of $22.9 billion, a 10% year-over-year decline driven by fewer value-based care patients in markets where Optum lacked sufficient care infrastructure. Despite the revenue contraction, earnings from operations improved sharply to $735 million and an operating margin of 3.2%, compared to just $41 million and 0.2% in the same period a year earlier. Optum Health's CEO acknowledged the recovery is a multi-year effort, describing a path to 6%-8% operating margins as a journey that will take several years to complete. For full-year 2026, Optum overall is expected to generate operating earnings greater than $13.2 billion on revenues above $257.5 billion, implying a roughly 5.1% margin.
Analysts largely maintained positive ratings on UNH following the report, though several cut their price targets after scrutinizing the results. Truist and KeyBanc both reiterated Buy and Overweight ratings, respectively, each with a $500 price target. Piper Sandler raised its target to $504, and UBS reiterated a Buy. Bernstein also stood by its rating, citing the strong earnings. A Yahoo Finance report noted that one large bank, after raising its target, projected potential gains of roughly 40% from UNH's then-depressed three-month price level. A separate Seeking Alpha analysis framed the quarter as UnitedHealth earning more from a smaller revenue base, pointing to the margin improvement as the key signal. Separately, Representative Kevin Hern disclosed selling up to $50,000 of UNH stock as part of a broader set of 18 sell transactions totaling up to roughly $945,000 across various holdings.
© AI-generated summary is provided by Market Flux
Sources
- MarketWatchDow rallies 184 points on gains for shares of UnitedHealth, Amgen
- Yahoo FinanceUnitedHealth is Down Big Over 3 Months: A Big Bank Says 40% Gains to Come After Raising Their Target
- NasdaqUnitedHealth Group (UNH) is a Top-Ranked Momentum Stock: Should You Buy?
- InvestingTruist reiterates Buy on UnitedHealth stock, keeps $500 target
- Seeking AlphaUnitedHealth Is Earning More From Less
- PelositrackerRep. Kevin Hern (R) just disclosed 18 new stock trades Every single one was a sell Buys: $0 Sells: up to ~$945K Including $LMT, $UNH, $CVX, $DVN, & more